Brief: MilliporeSigma And genOway Form CRISPR/Cas9 Alliance To Develop Rodent Models

genOway SA

10/12/2018 16:35

Dec 10 (Reuters) - MILLIPORESIGMA:
    * GENOWAY TO ACQUIRE EXCLUSIVE RIGHTS TO MILLIPORESIGMA'S
FOUNDATIONAL GENOME-EDITING PATENTS TO PRODUCE, SELL RODENT
MODELS
    * MILLIPORESIGMA AND GENOWAY FORM CRISPR/CAS9 STRATEGIC
ALLIANCE
TO DEVELOP RODENT MODELS

Source text for Eikon:  ID:nPn23LkYna 
Further company coverage:  ALGEN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))